Special Issue "Biology and Pathology of Tumor Viruses in Animals"
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Animal Viruses".
Deadline for manuscript submissions: closed (16 August 2023) | Viewed by 1587
Special Issue Editors
Interests: biology, prevention, and therapy of papillomavirus-induced tumor disease in horses and other species; squamous cell carcinoma; malignant melanoma
Interests: vaccines; immunology of infectious diseases; vaccination; viral immunology; molecular virology; immunization
Special Issue Information
Dear Colleagues,
As you all know, viruses such as papillomaviruses (PVs) and herpesviruses are increasingly recognized as cancer-promoting agents. In humans, for example, high-risk human PVs have been identified as the causative agents of virtually 100% of cervical cancers, about 50% of genital squamous cell carcinomas (SCCs), and up to 50% of head-and-neck SCCs. In addition, human gammaherpesviruses, i.e., Epstein–Barr virus and Kaposi's sarcoma, are accepted oncoviruses today.
Despite considerable advances within the past thirty years, animal oncovirus research considerably lags behind human research in this field with respect to funding and visibility. As such, there is a need to expand the study of animal oncoviruses.
In order to help improve the visibility of animal tumor virus research and generate more awareness regarding the importance of this research for the benefit of both animal and human patients, I invite you to contribute to a Special Issue on the “Biology and Pathology of Tumor Viruses in Animals”.
Research articles, short communications, and reviews are welcome for submission. Your contribution(s) could be, e.g., related to the following topics:
- tumor virus identification, genetics, prevalence;
- epidemiology, transmission and infection mechanisms;
- type of infection (productive, abortive, latent, integration, etc.);
- viral infection-mediated cell transformation;
- viral immune escape mechanisms;
- diagnosis and prognosis of virus-induced malignancies in animals;
- prevention and therapy of these malignancies including preclinical/clinical trials;
- comparative aspects: human versus animal tumor disease induced by oncoviruses.
Dr. Sabine Brandt
Dr. Christoph Jindra
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
